Current Dong-A management likely to win

Published: 2007-10-29 07:00:00

Updated: 2007-10-29 07:00:00

Pharmaceutical sources says the current management led by its incumbent Chairman Kang Shin-ho will get more advantageous position as Mirae Asset Investments, the largest shareholder of Dong-A Pharmaceutical, announced on October 23 that it sided with current Dong-A management.

The leading asset management firm made it clear that it is against the proposal to elect new executives recommended ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.